What is Labcorp Holdings's D&A?

Labcorp Holdings (LH) reported D&A of $75.6M in Q1 2026.

How has Labcorp Holdings's D&A changed year-over-year?

Labcorp Holdings's D&A increased by 8.6% year-over-year, from $69.6M to $75.6M.

What is the long-term trend for Labcorp Holdings's D&A?

Over 4 years (2021 to 2025), Labcorp Holdings's D&A has grown at a -1.4% compound annual growth rate (CAGR), from $296.6M to $280M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Labcorp Holdings LH D&A

D&A at other companies

Quest DiagnosticsDGX

$37M-5.1%

Charles River LaboratoriesCRL

$67.15M-44.2%

Castle BiosciencesCSTL

$2.23M-92.1%

IQVIAIQV

$288M+8.7%

Medpace Holdings, Inc.MEDP

$155K-34.3%

Natera, Inc.NTRA

——

Segments

By segment

See full

Diagnostics$63.8M+3.4%

Biopharma Laboratory Services$28.6M0.0%

Other financials

Income statement

See full

Revenue$3.5B+5.8%

Gross profit$1.0B+6.9%

Operating income$380.8M+16.8%

Net income$277.8M+30.5%

EPS (diluted)$3.35+32.9%

Balance sheet

See full

Cash & equivalents$981.1M+166%

Total debt$7.2B+11.1%

Total equity$8.7B+5.1%

Total assets$19.1B+8.4%

Cash flow

See full

Operating cash flow$191.5M+935%

CapEx$121.0M-4.0%

Free cash flow$70.5M+166%

Valuation

See full

Market cap$22.96B+9.4%

Enterprise value$29.22B+10.7%

P/E24.4×-3.1×

P/S1.6×+0.1×

Profitability

See full

Gross margin28.8%+0.9pp

Operating margin10.2%+1.9pp

Net margin6.7%+1.1pp

FCF margin9.8%+1.0pp

Returns & leverage

See full

Return on equity11.1%+2.1pp

Debt / equity0.8×0.0×

Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Labcorp Holdings's D&A?: Labcorp Holdings (LH) reported D&A of $75.6M in Q1 2026.
How has Labcorp Holdings's D&A changed year-over-year?: Labcorp Holdings's D&A increased by 8.6% year-over-year, from $69.6M to $75.6M.
What is the long-term trend for Labcorp Holdings's D&A?: Over 4 years (2021 to 2025), Labcorp Holdings's D&A has grown at a -1.4% compound annual growth rate (CAGR), from $296.6M to $280M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.